MELILLO, GIOVANNI,BALLAS, MARC,DOVEDI, SIMON,STEWART, ROSS
申请号：
CA3092632
公开号：
CA3092632A1
申请日:
2018.03.08
申请国别(地区):
CA
年份:
2019
代理人:
摘要：
Disclosed are methods for treating late stage (e.g., clinical stage III or IV), unresectable non-small-cell lung cancer (NSCLC) with an antibody that inhibits PD1/PD-L1 activity in a patient identified as having not progressed following definitive chemoradiation therapy.
